Effect of myofascial techniques for treatment of persistent arm pain after breast cancer treatment: randomized controlled trial
Objective: To investigate the effect of myofascial therapy in addition to a standard physical therapy program for treatment of persistent arm pain after finishing breast cancer treatment. Design: Double-blinded (patient and assessor) randomized controlled trial. Setting: University Hospitals Leuven,...
Gespeichert in:
Veröffentlicht in: | Clinical rehabilitation 2018-04, Vol.32 (4), p.451-461 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 461 |
---|---|
container_issue | 4 |
container_start_page | 451 |
container_title | Clinical rehabilitation |
container_volume | 32 |
creator | De Groef, An Van Kampen, Marijke Vervloesem, Nele Dieltjens, Evi Christiaens, Marie-Rose Neven, Patrick Vos, Lore De Vrieze, Tessa Geraerts, Inge Devoogdt, Nele |
description | Objective:
To investigate the effect of myofascial therapy in addition to a standard physical therapy program for treatment of persistent arm pain after finishing breast cancer treatment.
Design:
Double-blinded (patient and assessor) randomized controlled trial.
Setting:
University Hospitals Leuven, Belgium.
Patients:
A total of 50 patients with persistent arm pain and myofascial dysfunctions after breast cancer treatment.
Intervention:
Over three months, all patients received a standard physical therapy program. The intervention group received in addition 12 sessions of myofascial therapy, and the control group received 12 sessions of placebo therapy.
Main measurements:
Main outcome parameters were pain intensity (primary outcome) (maximum visual analogue scale (VAS) (0–100)), prevalence rate of arm pain, pressure hypersensitivity (pressure pain thresholds (kg/cm2) and pain quality (McGill Pain Questionnaire). Measures were taken before and after the intervention and at long term (6 and 12 months follow-up).
Results:
Patients in the intervention group had a significantly greater decrease in pain intensity compared to the control group (VAS −44/100 vs. −24/100, P = 0.046) with a mean difference in change after three months between groups of 20/100 (95% confidence interval, 0.4 to 39.7). After the intervention, 44% versus 64% of patients still experienced pain in the intervention and control group, respectively (P = 0.246). No significant differences were found for the other outcomes.
Conclusion:
Myofascial therapy is an effective physical therapy modality to decrease pain intensity at the arm in breast cancer survivors at three months, but no other benefits at that time were found. There were no long-term effects at 12 months either. |
doi_str_mv | 10.1177/0269215517730863 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1940058029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0269215517730863</sage_id><sourcerecordid>2016864527</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-35435db507c8b267021c7bf203839ae8174cfb686067b6755e76f80791adda823</originalsourceid><addsrcrecordid>eNp1kb1P3TAUxa2qqDxodyZkqQtL4NqOP9KteuJLQuoCc-Q4121QEr_afgMs_Os4fRQqpE6-1v2dc2wdQo4YnDKm9Rlw1XAmZZkFGCU-kBWrta7AaPGRrJZ1tez3yUFK9wBgeM0-kX1uGlYXaEWezr1Hl2nwdHoI3iY32JFmdL_m4fcWE_Uh0hzR5gnnP9gGYxpSXm42TnRjh5lanzHSrmApU2dnh_-IvtFo5z5MwyP21IU5xzCOZcyxRH0me96OCb-8nIfk7uL8dn1V3fy4vF5_v6mcUDJXQtZC9p0E7UzHlQbOnO48B2FEY9EwXTvfKaNA6U5pKVErb0A3zPa9NVwckpOd7yaG5V-5nYbkcBztjGGbWtbUANIAbwr69R16H7ZxLq9rObCSUUuuCwU7ysWQUkTfbuIw2fjQMmiXctr35RTJ8YvxtpuwfxX8baMA1Q5I9ie-pf7X8BlAUZdC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2016864527</pqid></control><display><type>article</type><title>Effect of myofascial techniques for treatment of persistent arm pain after breast cancer treatment: randomized controlled trial</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>SAGE Complete A-Z List</source><creator>De Groef, An ; Van Kampen, Marijke ; Vervloesem, Nele ; Dieltjens, Evi ; Christiaens, Marie-Rose ; Neven, Patrick ; Vos, Lore ; De Vrieze, Tessa ; Geraerts, Inge ; Devoogdt, Nele</creator><creatorcontrib>De Groef, An ; Van Kampen, Marijke ; Vervloesem, Nele ; Dieltjens, Evi ; Christiaens, Marie-Rose ; Neven, Patrick ; Vos, Lore ; De Vrieze, Tessa ; Geraerts, Inge ; Devoogdt, Nele</creatorcontrib><description>Objective:
To investigate the effect of myofascial therapy in addition to a standard physical therapy program for treatment of persistent arm pain after finishing breast cancer treatment.
Design:
Double-blinded (patient and assessor) randomized controlled trial.
Setting:
University Hospitals Leuven, Belgium.
Patients:
A total of 50 patients with persistent arm pain and myofascial dysfunctions after breast cancer treatment.
Intervention:
Over three months, all patients received a standard physical therapy program. The intervention group received in addition 12 sessions of myofascial therapy, and the control group received 12 sessions of placebo therapy.
Main measurements:
Main outcome parameters were pain intensity (primary outcome) (maximum visual analogue scale (VAS) (0–100)), prevalence rate of arm pain, pressure hypersensitivity (pressure pain thresholds (kg/cm2) and pain quality (McGill Pain Questionnaire). Measures were taken before and after the intervention and at long term (6 and 12 months follow-up).
Results:
Patients in the intervention group had a significantly greater decrease in pain intensity compared to the control group (VAS −44/100 vs. −24/100, P = 0.046) with a mean difference in change after three months between groups of 20/100 (95% confidence interval, 0.4 to 39.7). After the intervention, 44% versus 64% of patients still experienced pain in the intervention and control group, respectively (P = 0.246). No significant differences were found for the other outcomes.
Conclusion:
Myofascial therapy is an effective physical therapy modality to decrease pain intensity at the arm in breast cancer survivors at three months, but no other benefits at that time were found. There were no long-term effects at 12 months either.</description><identifier>ISSN: 0269-2155</identifier><identifier>EISSN: 1477-0873</identifier><identifier>DOI: 10.1177/0269215517730863</identifier><identifier>PMID: 28914087</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Arms ; Assessors ; Breast cancer ; Cancer therapies ; Clinical trials ; Confidence intervals ; Control groups ; Evidence-based medicine ; Group therapy ; Hospitals ; Hypersensitivity ; Intervention ; Long term ; Pain ; Physical therapy ; Physiotherapy ; Questionnaires ; Survivor ; Thresholds</subject><ispartof>Clinical rehabilitation, 2018-04, Vol.32 (4), p.451-461</ispartof><rights>The Author(s) 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-35435db507c8b267021c7bf203839ae8174cfb686067b6755e76f80791adda823</citedby><cites>FETCH-LOGICAL-c365t-35435db507c8b267021c7bf203839ae8174cfb686067b6755e76f80791adda823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0269215517730863$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0269215517730863$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,30999,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28914087$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Groef, An</creatorcontrib><creatorcontrib>Van Kampen, Marijke</creatorcontrib><creatorcontrib>Vervloesem, Nele</creatorcontrib><creatorcontrib>Dieltjens, Evi</creatorcontrib><creatorcontrib>Christiaens, Marie-Rose</creatorcontrib><creatorcontrib>Neven, Patrick</creatorcontrib><creatorcontrib>Vos, Lore</creatorcontrib><creatorcontrib>De Vrieze, Tessa</creatorcontrib><creatorcontrib>Geraerts, Inge</creatorcontrib><creatorcontrib>Devoogdt, Nele</creatorcontrib><title>Effect of myofascial techniques for treatment of persistent arm pain after breast cancer treatment: randomized controlled trial</title><title>Clinical rehabilitation</title><addtitle>Clin Rehabil</addtitle><description>Objective:
To investigate the effect of myofascial therapy in addition to a standard physical therapy program for treatment of persistent arm pain after finishing breast cancer treatment.
Design:
Double-blinded (patient and assessor) randomized controlled trial.
Setting:
University Hospitals Leuven, Belgium.
Patients:
A total of 50 patients with persistent arm pain and myofascial dysfunctions after breast cancer treatment.
Intervention:
Over three months, all patients received a standard physical therapy program. The intervention group received in addition 12 sessions of myofascial therapy, and the control group received 12 sessions of placebo therapy.
Main measurements:
Main outcome parameters were pain intensity (primary outcome) (maximum visual analogue scale (VAS) (0–100)), prevalence rate of arm pain, pressure hypersensitivity (pressure pain thresholds (kg/cm2) and pain quality (McGill Pain Questionnaire). Measures were taken before and after the intervention and at long term (6 and 12 months follow-up).
Results:
Patients in the intervention group had a significantly greater decrease in pain intensity compared to the control group (VAS −44/100 vs. −24/100, P = 0.046) with a mean difference in change after three months between groups of 20/100 (95% confidence interval, 0.4 to 39.7). After the intervention, 44% versus 64% of patients still experienced pain in the intervention and control group, respectively (P = 0.246). No significant differences were found for the other outcomes.
Conclusion:
Myofascial therapy is an effective physical therapy modality to decrease pain intensity at the arm in breast cancer survivors at three months, but no other benefits at that time were found. There were no long-term effects at 12 months either.</description><subject>Arms</subject><subject>Assessors</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Clinical trials</subject><subject>Confidence intervals</subject><subject>Control groups</subject><subject>Evidence-based medicine</subject><subject>Group therapy</subject><subject>Hospitals</subject><subject>Hypersensitivity</subject><subject>Intervention</subject><subject>Long term</subject><subject>Pain</subject><subject>Physical therapy</subject><subject>Physiotherapy</subject><subject>Questionnaires</subject><subject>Survivor</subject><subject>Thresholds</subject><issn>0269-2155</issn><issn>1477-0873</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNp1kb1P3TAUxa2qqDxodyZkqQtL4NqOP9KteuJLQuoCc-Q4121QEr_afgMs_Os4fRQqpE6-1v2dc2wdQo4YnDKm9Rlw1XAmZZkFGCU-kBWrta7AaPGRrJZ1tez3yUFK9wBgeM0-kX1uGlYXaEWezr1Hl2nwdHoI3iY32JFmdL_m4fcWE_Uh0hzR5gnnP9gGYxpSXm42TnRjh5lanzHSrmApU2dnh_-IvtFo5z5MwyP21IU5xzCOZcyxRH0me96OCb-8nIfk7uL8dn1V3fy4vF5_v6mcUDJXQtZC9p0E7UzHlQbOnO48B2FEY9EwXTvfKaNA6U5pKVErb0A3zPa9NVwckpOd7yaG5V-5nYbkcBztjGGbWtbUANIAbwr69R16H7ZxLq9rObCSUUuuCwU7ysWQUkTfbuIw2fjQMmiXctr35RTJ8YvxtpuwfxX8baMA1Q5I9ie-pf7X8BlAUZdC</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>De Groef, An</creator><creator>Van Kampen, Marijke</creator><creator>Vervloesem, Nele</creator><creator>Dieltjens, Evi</creator><creator>Christiaens, Marie-Rose</creator><creator>Neven, Patrick</creator><creator>Vos, Lore</creator><creator>De Vrieze, Tessa</creator><creator>Geraerts, Inge</creator><creator>Devoogdt, Nele</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201804</creationdate><title>Effect of myofascial techniques for treatment of persistent arm pain after breast cancer treatment: randomized controlled trial</title><author>De Groef, An ; Van Kampen, Marijke ; Vervloesem, Nele ; Dieltjens, Evi ; Christiaens, Marie-Rose ; Neven, Patrick ; Vos, Lore ; De Vrieze, Tessa ; Geraerts, Inge ; Devoogdt, Nele</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-35435db507c8b267021c7bf203839ae8174cfb686067b6755e76f80791adda823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Arms</topic><topic>Assessors</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Clinical trials</topic><topic>Confidence intervals</topic><topic>Control groups</topic><topic>Evidence-based medicine</topic><topic>Group therapy</topic><topic>Hospitals</topic><topic>Hypersensitivity</topic><topic>Intervention</topic><topic>Long term</topic><topic>Pain</topic><topic>Physical therapy</topic><topic>Physiotherapy</topic><topic>Questionnaires</topic><topic>Survivor</topic><topic>Thresholds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Groef, An</creatorcontrib><creatorcontrib>Van Kampen, Marijke</creatorcontrib><creatorcontrib>Vervloesem, Nele</creatorcontrib><creatorcontrib>Dieltjens, Evi</creatorcontrib><creatorcontrib>Christiaens, Marie-Rose</creatorcontrib><creatorcontrib>Neven, Patrick</creatorcontrib><creatorcontrib>Vos, Lore</creatorcontrib><creatorcontrib>De Vrieze, Tessa</creatorcontrib><creatorcontrib>Geraerts, Inge</creatorcontrib><creatorcontrib>Devoogdt, Nele</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical rehabilitation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Groef, An</au><au>Van Kampen, Marijke</au><au>Vervloesem, Nele</au><au>Dieltjens, Evi</au><au>Christiaens, Marie-Rose</au><au>Neven, Patrick</au><au>Vos, Lore</au><au>De Vrieze, Tessa</au><au>Geraerts, Inge</au><au>Devoogdt, Nele</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of myofascial techniques for treatment of persistent arm pain after breast cancer treatment: randomized controlled trial</atitle><jtitle>Clinical rehabilitation</jtitle><addtitle>Clin Rehabil</addtitle><date>2018-04</date><risdate>2018</risdate><volume>32</volume><issue>4</issue><spage>451</spage><epage>461</epage><pages>451-461</pages><issn>0269-2155</issn><eissn>1477-0873</eissn><abstract>Objective:
To investigate the effect of myofascial therapy in addition to a standard physical therapy program for treatment of persistent arm pain after finishing breast cancer treatment.
Design:
Double-blinded (patient and assessor) randomized controlled trial.
Setting:
University Hospitals Leuven, Belgium.
Patients:
A total of 50 patients with persistent arm pain and myofascial dysfunctions after breast cancer treatment.
Intervention:
Over three months, all patients received a standard physical therapy program. The intervention group received in addition 12 sessions of myofascial therapy, and the control group received 12 sessions of placebo therapy.
Main measurements:
Main outcome parameters were pain intensity (primary outcome) (maximum visual analogue scale (VAS) (0–100)), prevalence rate of arm pain, pressure hypersensitivity (pressure pain thresholds (kg/cm2) and pain quality (McGill Pain Questionnaire). Measures were taken before and after the intervention and at long term (6 and 12 months follow-up).
Results:
Patients in the intervention group had a significantly greater decrease in pain intensity compared to the control group (VAS −44/100 vs. −24/100, P = 0.046) with a mean difference in change after three months between groups of 20/100 (95% confidence interval, 0.4 to 39.7). After the intervention, 44% versus 64% of patients still experienced pain in the intervention and control group, respectively (P = 0.246). No significant differences were found for the other outcomes.
Conclusion:
Myofascial therapy is an effective physical therapy modality to decrease pain intensity at the arm in breast cancer survivors at three months, but no other benefits at that time were found. There were no long-term effects at 12 months either.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>28914087</pmid><doi>10.1177/0269215517730863</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0269-2155 |
ispartof | Clinical rehabilitation, 2018-04, Vol.32 (4), p.451-461 |
issn | 0269-2155 1477-0873 |
language | eng |
recordid | cdi_proquest_miscellaneous_1940058029 |
source | Applied Social Sciences Index & Abstracts (ASSIA); SAGE Complete A-Z List |
subjects | Arms Assessors Breast cancer Cancer therapies Clinical trials Confidence intervals Control groups Evidence-based medicine Group therapy Hospitals Hypersensitivity Intervention Long term Pain Physical therapy Physiotherapy Questionnaires Survivor Thresholds |
title | Effect of myofascial techniques for treatment of persistent arm pain after breast cancer treatment: randomized controlled trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A00%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20myofascial%20techniques%20for%20treatment%20of%20persistent%20arm%20pain%20after%20breast%20cancer%20treatment:%20randomized%20controlled%20trial&rft.jtitle=Clinical%20rehabilitation&rft.au=De%20Groef,%20An&rft.date=2018-04&rft.volume=32&rft.issue=4&rft.spage=451&rft.epage=461&rft.pages=451-461&rft.issn=0269-2155&rft.eissn=1477-0873&rft_id=info:doi/10.1177/0269215517730863&rft_dat=%3Cproquest_cross%3E2016864527%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2016864527&rft_id=info:pmid/28914087&rft_sage_id=10.1177_0269215517730863&rfr_iscdi=true |